Golden State Wealth Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1776033 SANTA ANA, CA

Position in VRTX

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$101,364

-$11,976 QoQ

Shares Held

227

-9.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Golden State Wealth Management, LLC holds $302,550 across 26 Biotechnology names. VRTX ranks #1 (33.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	227	$101,364
2	IBRX	ImmunityBio, Inc.	4,700	$36,049
3	IONS	Ionis Pharmaceuticals Inc	376	$28,233
4	VKTX	Viking Therapeutics, Inc.	790	$25,706
5	ALGS	Aligos Therapeutics, Inc.	2,674	$19,867
6	INCY	Incyte Corp	176	$16,565
7	SMMT	Summit Therapeutics Inc.	828	$15,698
8	REGN	Regeneron Pharmaceuticals, Inc.	20	$15,452

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$101,364	227	-9.2%	Shares	Sole	2026-04-28
2025-12-31	$113,340	250	-5.7%	Shares	Sole	2026-02-13
2025-09-30	$103,784	265	+3.5%	Shares	Sole	2025-11-03
2025-06-30	$113,971	256	+169.5%	Shares	Sole	2025-08-06
2025-03-31	$46,057	95	+4.4%	Shares	Sole	2025-04-24
2024-12-31	$36,645	91	-90.5%	Shares	Sole	2025-01-28
2021-12-31	$211,035	961	-9.8%	Shares	Sole	2022-02-14
2021-06-30	$214,735	1,065	+1400.0%	Shares	Sole	2021-08-12
2020-03-31	$16,894	71	—	Shares	Sole	2020-04-17
No filing history on record for this holder in this stock.